What amount sold does ZALICO VL Series Account - 2 report in Form D filings?

The latest linked filings report $4.3M sold across 1 identified offering(s). 17 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ZALICO VL Series Account - 2's most recent SEC filing?

ZALICO VL Series Account - 2's most recent Form D filing was on 2025-05-21.

How many investors does ZALICO VL Series Account - 2 have?

The most recent Form D filing lists 1 investor(s).

ZALICO VL Series Account - 2

CIK: 0001519435·Insurance·SCHAUMBURG, IL·Other

Reported Sold

$4,283,722

Total Filings

Identified Offerings

Last Filed

May 21, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 17 unlinked amendments excluded.

About

Company in Insurance industry

SEC EDGAR

Offering filing timeline

May 21, 2025Form D/A — Amendment

Reported sold: $1,611,050,149 · Target: Indefinite

Rule 506(c)·27 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

May 21, 2025Form D/A — Amendment

Reported sold: $8,083,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Apr 3, 2024Form D/A — Amendment

Reported sold: $1,038,925,097 · Target: Indefinite

Rule 506(c)·16 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Apr 3, 2024Form D/A — Amendment

Reported sold: $8,083,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Aug 23, 2023Form D/A — Amendment

Reported sold: $985,105,310 · Target: Indefinite

Rule 506(c)·15 investors·Section 3(c), Section 3(c)(7)

Changed: Sales commissions

Aug 23, 2023Form D/A — Amendment

Reported sold: $8,083,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Sep 13, 2022Form D/A — Amendment

Reported sold: $7,483,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Sales commissions

Sep 8, 2022Form D/A — Amendment

Reported sold: $985,105,310 · Target: Indefinite

Rule 506(c)·15 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 9, 2021Form D/A — Amendment

Reported sold: $6,483,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Nov 8, 2021Form D/A — Amendment

Reported sold: $845,785,310 · Target: Indefinite

Rule 506(c)·14 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Oct 14, 2020Form D/A — Amendment

Reported sold: $833,395,310 · Target: Indefinite

Rule 506(c)·14 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Sep 17, 2019Form D/A — Amendment

Reported sold: $569,695,310 · Target: Indefinite

Rule 506(c)·11 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Sep 17, 2019Form D/A — Amendment

Reported sold: $4,283,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Sales commissions

Oct 4, 2018Form D/A — Amendment

Reported sold: $478,487,600 · Target: Indefinite

Rule 506(c)·10 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Oct 2, 2018Form D/A — Amendment

Reported sold: $3,987,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Nov 14, 2017Form D/A — Amendment

Reported sold: $438,487,600 · Target: Indefinite

Rule 506(c)·10 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Nov 14, 2017Form D/A — Amendment

Reported sold: $3,910,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Nov 3, 2017Form D/A — Amendment

Reported sold: $3,910,722 · Target: Indefinite

Rule 506(c)·1 investor·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Dec 21, 2016Form D/A — Amendment

Reported sold: $385,542,600 · Target: Indefinite

Rule 506(c)·8 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Sep 8, 2016Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(c)·0 investors·Section 3(c), Section 3(c)(7)

Dec 22, 2015Form D/A — Amendment

Reported sold: $319,042,600 · Target: Indefinite

Rule 506(c)·7 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Dec 4, 2014Form D/A — Amendment

Reported sold: $109,500,000 · Target: Indefinite

No verified predecessor available.

Rule 506(c)·2 investors·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$58,658

Amendment Rate

95%

Latest reported sold across 1 identified offering

$4,283,722

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

17 unlinked amendments excluded.

Key People

Michael Rohwetter

Related Person

Appears on 22 filings

Richard Hauser

Related Person

Appears on 16 filings

Cathy Ehrlich

Related Person

Appears on 14 filings

Eoin McNamara

Related Person

Appears on 13 filings

Farah Rehman

Related Person

Appears on 13 filings

Patrick Carty

Related Person

Appears on 12 filings

David Dietz

Related Person

Appears on 12 filings

Stuart Berman

Related Person

Appears on 11 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
May 21, 2025	Amendment	Indefinite	$8,083,722	1
May 21, 2025	Amendment	Indefinite	$1,611,050,149	27
Apr 3, 2024	Amendment	Indefinite	$8,083,722	1
Apr 3, 2024	Amendment	Indefinite	$1,038,925,097	16
Aug 23, 2023	Amendment	Indefinite	$8,083,722	1
Aug 23, 2023	Amendment	Indefinite	$985,105,310	15
Sep 13, 2022	Amendment	Indefinite	$7,483,722	1
Sep 8, 2022	Amendment	Indefinite	$985,105,310	15
Nov 9, 2021	Amendment	Indefinite	$6,483,722	1
Nov 8, 2021	Amendment	Indefinite	$845,785,310	14
Oct 14, 2020	Amendment	Indefinite	$833,395,310	14
Sep 17, 2019	Amendment	Indefinite	$4,283,722	1
Sep 17, 2019	Amendment	Indefinite	$569,695,310	11
Oct 4, 2018	Amendment	Indefinite	$478,487,600	10
Oct 2, 2018	Amendment	Indefinite	$3,987,722	1
Nov 14, 2017	Amendment	Indefinite	$3,910,722	1
Nov 14, 2017	Amendment	Indefinite	$438,487,600	10
Nov 3, 2017	Amendment	Indefinite	$3,910,722	1
Dec 21, 2016	Amendment	Indefinite	$385,542,600	8
Dec 20, 2016	Amendment	Indefinite	$385,542,600	8
Sep 8, 2016	New	Indefinite	$0	0
Dec 22, 2015	Amendment	Indefinite	$319,042,600	7
Dec 4, 2014	Amendment	Indefinite	$109,500,000	2
Dec 20, 2013	Amendment	Indefinite	$109,500,000	2
Nov 29, 2012	Amendment	Indefinite	$109,500,000	2
Jul 27, 2011	New	Indefinite	$75,000,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Redan Holdings Group LLC

Insurance

Offering target: $1,052,173

Filed Sep 11, 2026